Key result
Sympathetic beta-blockade with metoprolol or propranolol did not change tilt tolerance or associated hypotension and bradycardia during sustained head-up tilt, but prevented heart rate elevation.
Why the study?
Does beta-blockade with metoprolol or propranolol alter cardiovascular responses or tilt tolerance during sustained head-up tilt in males?
Does beta-blockade with metoprolol or propranolol alter cardiovascular responses or tilt tolerance during sustained head-up tilt in males?
Sympathetic activation is crucial for heart rate elevation during normotensive head-up tilt, but not for tilt tolerance or the associated hypotension and bradycardia.
Beta-blockade need not alter tilt tolerance concerns in practice; leaves open sympathetic roles in orthostatic hypotension beyond heart rate.
Sympathetic beta-adrenergic influences on cardiovascular responses to 50 degrees head-up tilt were evaluated with metoprolol (beta 1-blockade; 0.29 mg kg-1) and propranolol (beta 1 and beta 2-blockade; 0.28 mg kg-1) in eight males. A normotensive-tachycardic phase was followed by a hypotensive-bradycardic episode associated with presyncopal symptoms after 23 +/- 3 min (control, mean +/- SE). Head-up tilt made thoracic electrical impedance (3.0 +/- 1.0 omega), mean arterial pressure (MAP, 86 +/- 4-93 +/- 4 mmHg), heart rate (HR, 63 +/- 3-99 +/- 10 beats min-1) and total peripheral resistance (TPR, 15 +/- 1-28 +/- 4 mmHg min L-1) increase, while central venous oxygen saturation (74 +/- 2-58 +/- 4%), cardiac output (5.7 +/- 0.1-3.1 +/- 0.3 L min-1), stroke volume (95 +/- 6-41 +/- 5 mL) and pulse pressure (55 +/- 4-49 +/- 4 mmHg) decreased (P < 0.05). Central venous pressure decreased during head-up tilt (7 +/- 2-0 +/- 1 mmHg), but it remained stable during the sustained tilt. At the appearance of presyncopal symptoms MAP (49 +/- 3 mmHg), HR (66 +/- 4 beats min-1) and TPR (15 +/- 3 mmHg min L-1) decreased (P < 0.05). Neither metoprolol or propranolol changed tilt tolerance or cardiovascular variables, except for HR that remained at 57 +/- 2 (metoprolol) and 55 +/- 3 beats min-1 (propranolol), and MAP that remained at 87 +/- 5 mmHg during the first phase with metoprolol. In conclusion, sympathetic activation was crucial for the heart rate elevation during normotensive head-up tilt, but not for tilt tolerance or for the associated hypotension and bradycardia.
No takes yet. Share an insight, caveat, or question.
Pedersen et al. (1995) studied Cardiovascular responses to sustained head-up tilt (n=8). Metoprolol and propranolol vs. Control was evaluated on Tilt tolerance and cardiovascular variables. Sympathetic beta-blockade with metoprolol or propranolol did not change tilt tolerance or associated hypotension and bradycardia during sustained head-up tilt, but prevented heart rate elevation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: